Cyranose® 320
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Overview
Cyranose® 320 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Cyranose® 320 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Cyranose® 320 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.